Opportunity Information: Apply for RFA DA 20 007

The National Institutes of Health announced this discretionary grant opportunity, RFA-DA-20-007, titled "Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21 - Clinical Trials Not Allowed)." It uses the R21 mechanism, which is generally intended for exploratory, high-risk/high-reward projects that can generate proof-of-concept results, new directions, or early-stage methods rather than fully mature, large-scale research programs. As the title indicates, clinical trials are not allowed under this funding opportunity, so the work should focus on computational, analytical, and data-driven approaches rather than testing clinical interventions in human participants.

The core goal of the program is to bring more data and computational scientists into addiction and substance use disorder research by encouraging proposals that can integrate and analyze complex datasets that differ in type and scale. In practical terms, this means the NIH is looking for teams that can combine information across levels such as molecular or genomic data, neural circuit or brain imaging data, physiological measures, behavioral data, and other relevant sources in ways that traditional analysis pipelines do not handle well. The emphasis is on developing and applying novel computational, bioinformatics, statistical, and analytical methods that make it possible to ask new questions, find patterns that were previously hidden, and generate insights into the biology of addiction that could not be reached through single-dataset or single-modality approaches.

A major theme in the description is innovation in data integration. The opportunity is not just asking applicants to run standard analyses on existing datasets; it is specifically encouraging new frameworks, tools, or strategies that can connect disparate datasets, harmonize them, and support new types of inference. Examples of the kind of technical direction implied by the language include multimodal data fusion, advanced machine learning or network-based modeling, scalable pipelines for very large datasets, methods for handling data heterogeneity and missingness, and approaches that enable interpretable links between neural mechanisms and addiction-related phenotypes. The intended payoff is that these methods will unlock "previously inaccessible insights" and reveal new aspects of addiction biology, particularly as it relates to neural mechanisms and substance use disorder.

In terms of who can apply, eligibility is broad and spans many sectors. Eligible applicants include various levels of government (state, county, city or township, and special district governments), independent school districts, public and state-controlled institutions of higher education, and private institutions of higher education. The opportunity is also open to federally recognized Native American tribal governments, tribal organizations that are not federally recognized, public housing authorities and Indian housing authorities, and a range of nonprofit organizations both with and without 501(c)(3) status. For-profit organizations (other than small businesses) and small businesses are listed as eligible as well, along with an "Others" category that NIH uses to capture additional eligible entity types. The announcement also explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). Taken together, this signals an intent to broaden participation and encourage cross-disciplinary and cross-institutional collaborations, including organizations that may bring unique datasets, community connections, or specialized computational expertise.

From an administrative standpoint, the funding instrument is a grant, the agency is the NIH, and the activity category is listed under education and health, with CFDA number 93.279. The original closing date in the source information is November 14, 2019, and the creation date is July 10, 2019. The award ceiling and expected number of awards are not specified in the provided excerpt, which often means applicants would need to consult the full FOA text for budget limits, project period expectations, and any institute- or program-specific constraints tied to the R21 mechanism.

Overall, this opportunity is best understood as a call for methodologically ambitious, data-centric projects that can connect the dots across complex addiction-related datasets to clarify neural and biological mechanisms. The NIH is explicitly trying to stimulate new analytical capabilities in the field by attracting researchers who specialize in computation, statistics, bioinformatics, and big data science, with the expectation that these tools will open up new lines of discovery in addiction and substance use disorder research without conducting clinical trials.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21 - Clinical Trials Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2019-07-10.
  • Applicants must submit their applications by 2019-11-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DA 20 007

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

Previous opportunity: Sponsored Programs Administration Development (SPAD) Program (UC2 - Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 20 007

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 20 007) also looked into and applied for these:

Funding Opportunity
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed) Apply for RFA DA 20 023

Funding Number: RFA DA 20 023
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) Apply for RFA CA 19 057

Funding Number: RFA CA 19 057
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clinical Trial Optional) Apply for PAR 19 318

Funding Number: PAR 19 318
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) Apply for RFA CA 19 045

Funding Number: RFA CA 19 045
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $2,500,000
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 19 046

Funding Number: RFA CA 19 046
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Apply for PAR 19 325

Funding Number: PAR 19 325
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Palliative Care in Home and Community Settings (R21 Clinical Trial Optional) Apply for PAR 19 320

Funding Number: PAR 19 320
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional) Apply for PAR 19 326

Funding Number: PAR 19 326
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Palliative Care in Home and Community Settings (R01 Clinical Trial Optional) Apply for PAR 19 321

Funding Number: PAR 19 321
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) Apply for PAR 19 327

Funding Number: PAR 19 327
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Circadian Patterns of Gene Expression Associated with Disease (R01 - Clinical Trial Optional) Apply for RFA HL 20 016

Funding Number: RFA HL 20 016
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Apply for PAR 19 340

Funding Number: PAR 19 340
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Apply for PAR 19 339

Funding Number: PAR 19 339
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) Apply for PAR 19 349

Funding Number: PAR 19 349
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) Apply for PAR 19 345

Funding Number: PAR 19 345
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Apply for PAR 19 348

Funding Number: PAR 19 348
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Apply for PAR 19 350

Funding Number: PAR 19 350
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Apply for PAR 19 356

Funding Number: PAR 19 356
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) Apply for PAR 19 354

Funding Number: PAR 19 354
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) Apply for PAR 19 353

Funding Number: PAR 19 353
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 20 007", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: